<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">The SARS-CoV-2 is an RNA virus (family Coronaviridiae), similar to SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome Coronavirus) [
 <xref rid="bib0005" ref-type="bibr">1</xref>,
 <xref rid="bib0010" ref-type="bibr">2</xref>]. The 3 main symptoms of COVID-19 are fever, cough, and shortness of breath. Less common symptoms are muscle pain, anorexia, malaise, sore throat, nasal congestion, dyspnoea, and headache with an onset between 2 and 14 days. The clinical severity ranges widely from asymptomatic infection to fatal disease. The involvement of the upper respiratory district and lung is typical and primary. Radiological features include interstitial thickening, lung opacities, lower lobe predominance, and bronchiectasis; multifocal peripheral subpleural ground-glass opacification or consolidation has been commonly observed CT feature up to pleural and pericardial effusion, with symptoms ranging from flu syndrome to acute respiratory distress syndrome (ARDS), caused by diffuse alveolar damage (DAD), with cardiovascular and multiple organ failure till death [
 <xref rid="bib0015" ref-type="bibr">[3]</xref>, 
 <xref rid="bib0020" ref-type="bibr">[4]</xref>, 
 <xref rid="bib0025" ref-type="bibr">[5]</xref>].
</p>
